Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Kaltenbach

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Journal of the American Heart Association|April 18, 2020
Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance ProgramsJacob A Doll, Lisa A Kaltenbach, Kevin J Anstrom, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2012
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease programFeng Qian, Frederick S Ling, Prakash Deedwania, et al.
Circulation|December 28, 2018
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary InterventionAlexander C Fanaroff, Pearl Zakroysky, Daniel Wojdyla, et al.
JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 7, 2017
Outcomes of a multi-community hypertension implementation study: the American Heart Association's Check. Change. Control. programMonique L Anderson, Rachel Peragallo Urrutia, Emily C O'Brien, et al.
JACC. Advances|January 20, 2026
Outcomes in Patients With Atrial Fibrillation Stratified by Body Mass Index and Heart Failure StatusJean Jacques Noubiap, Lisa A Kaltenbach, Karen Chiswell, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2020
Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|October 26, 2022
Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation RegistryUtibe R Essien, Karen Chiswell, Lisa A Kaltenbach, et al.
JACC. Cardiovascular Interventions|April 4, 2021
Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral ApproachDavid A Manly, Wassef Karrowni, Jennifer A Rymer, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Journal of the American Heart Association|April 18, 2020
Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance ProgramsJacob A Doll, Lisa A Kaltenbach, Kevin J Anstrom, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2012
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease programFeng Qian, Frederick S Ling, Prakash Deedwania, et al.
Circulation|December 28, 2018
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary InterventionAlexander C Fanaroff, Pearl Zakroysky, Daniel Wojdyla, et al.
JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 7, 2017
Outcomes of a multi-community hypertension implementation study: the American Heart Association's Check. Change. Control. programMonique L Anderson, Rachel Peragallo Urrutia, Emily C O'Brien, et al.
JACC. Advances|January 20, 2026
Outcomes in Patients With Atrial Fibrillation Stratified by Body Mass Index and Heart Failure StatusJean Jacques Noubiap, Lisa A Kaltenbach, Karen Chiswell, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2020
Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
JAMA Cardiology|October 26, 2022
Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation RegistryUtibe R Essien, Karen Chiswell, Lisa A Kaltenbach, et al.
JACC. Cardiovascular Interventions|April 4, 2021
Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral ApproachDavid A Manly, Wassef Karrowni, Jennifer A Rymer, et al.
Pageof 7